Tag: tumor treating fields

Complement mutation linked to poor response to eculizumab

Tumor Treating Fields vs Standard Therapy in Treatment-Resistant Metastatic NSCLC

byDaniel Goldshteinand1 others

September 25, 2023

1. The median OS was 13.2 months with TTFields arm vs 9.9 months with standard arm, with an HR of ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Plasma progranulin levels are correlated with left ventricular function recovery following myocardial infarction
#VisualAbstract: No Difference Between Initial Intraosseous and Intravenous Vascular Access for Out-of-Hospital Cardiac Arrest
Multi-component sleep-mood group interventions may improve insomnia symptoms in young adults

No Result

View All Result

Tag: tumor treating fields

Tumor Treating Fields vs Standard Therapy in Treatment-Resistant Metastatic NSCLC

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports